The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Adolescents Without Diabetes Mellitus: A Systematic Review and Meta-Analysis.
GLP-1 受體激動劑在無糖尿病的超重/肥胖青少年中的抗肥胖效果及安全性:系統性回顧與統合分析。
Cureus 2024-09-06
Efficacy of Semaglutide in Treating Obesity: A Systematic Review of Randomized Controlled Trials (RCTs).
Semaglutide治療肥胖的功效:隨機對照試驗(RCTs)的系統性回顧。
Cureus 2023-01-20
The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.
GLP-1RAs(胰高血糖素樣肽-1受體激動劑)對超重或肥胖非糖尿病人群的減重效應:一項隨機對照試驗的系統性回顧與荟萃分析及試驗序列分析。
Am J Clin Nutr 2023-09-05
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis.
肥胖且無糖尿病個體中胰高血糖素樣肽-1受體激動劑對體重和心臟代謝參數的功效和安全性:系統性回顧和荟萃分析。
Endocr Pract 2024-02-06
Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysis.
肥胖患者 GLP-1RAs 的功效和安全性:基於 RCT 和貝葉斯網絡荟萃分析的系統性回顧。
Biomed Pharmacother 2024-02-15
A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists.
使用胰高血糖素樣肽-1受體激動劑的安全性和有效性評論與荟萃分析。
Medicina (Kaunas) 2024-03-30
The efficacy and safety of GLP-1 receptor agonists in youth with type 2 diabetes: a meta-analysis.
GLP-1 受體激動劑在青少年型2糖尿病患者中的療效和安全性:一項荟萃分析。
Diabetol Metab Syndr 2024-04-27
Efficacy of Glucagon-like Peptide-1 Receptor Agonists in Overweight/Obese and/or T2DM Adolescents: A Meta-analysis Based on Randomized Controlled Trials.
Glucagon-like Peptide-1 受體激動劑在超重/肥胖和/或第2型糖尿病青少年中的功效:基於隨機對照試驗的荟萃分析。
J Clin Res Pediatr Endocrinol 2024-06-03
Glucagon-like peptide-1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity-a systematic review and network meta-analysis.
青少年超重或肥胖伴隨或不伴隨第二型糖尿病多重共病的胰高血糖素樣肽-1受體激動劑系統性回顧與網絡Meta分析。
Diabetes Obes Metab 2024-07-23
Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis.
兒童及青少年肥胖或超重中胰高血糖素樣肽-1受體激動劑的比較療效與安全性:系統性回顧與網絡Meta分析。
Pharmaceuticals (Basel) 2024-07-27